Participant diversity is taking on a new significance for sponsors and CROs following recent Food and Drug Administration (FDA) guidance revisions. Learn how KMR, a WCG company, is leveraging extensive trial- and site-level data to provide analysis on diversity in clinical trials. Understand current insights and explore how data-driven solutions can help to improve diversity across the industry.
Watch our webinar on this important topic to elevate your diversity, equity, and inclusion (DEI) strategies.
During this session, WCG experts will:
- Provide an overview of the FDA guidance on diversity.
- Examine the current state of the industry.
- Share key insights gathered from extensive data analysis.
- Discuss the future of diversity analysis and explore data solutions.
Discover more data insights from KMR with the 2024 R&D Insights & Analytics Report.
Empower your strategy with comprehensive benchmarks and performance metrics in
biopharmaceutical research and development.
Learn More About our Benchmarking Capabilities
KMR, a WCG company, has been working exclusively in the biopharmaceutical R&D industry since 1990 as a leader in benchmarking, analytics, and performance management. Using its extensive peerless datasets and experience, KMR provides data-driven solutions to the most pressing business questions within the industry.
Request info about our clinical trial benchmarking reports and solutions to optimize study success.
To connect with an expert on precision analytics to enhance your trial, complete this form.